Screening men for abdominal aortic aneurysm: 10 Year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study

BMJ (Online)

Volumn 338, Issue 7710, 2009, Pages 1538-

  Thompson, S G ^a   Ashton, H A ^b   Gao, L ^a   Scott, R A P ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ST RICHARD S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; AGED; ANEURYSM SURGERY; ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECHOGRAPHY; FOLLOW UP; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; UNITED KINGDOM;

AGED; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; COST-BENEFIT ANALYSIS; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MASS SCREENING; RISK FACTORS;

EID: 67650045589     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2307     Document Type: Article

References (37)

1. UK National Screening Committee. Abdominal aortic aneurysm screening, May 2007. 2008. www.library.nhs.uk/screening/.
2. NHS National Services Scotland. Abdominal aortic aneurysm (AAA) screening, Aug 2008. www.nhsnss.org/uploads/board-papers/B0893%20AAAScreening. pdf.
3. US Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med 2005;142:198-202.
4. Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002;360:1531-9.
5. Kim LG, Scott RAP, Ashton HA, Thompson SG. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007;146:699-706.
6. Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the US Preventive Services Task Force. Ann Intern Med 2005;142:203-11.
7. Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev 2007;(2):CD002945.
8. Ashton HA, Gao L, Kim LG, Druce PS, Thompson SG, Scott RAP. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg 2007;94:696-701.
9. Hafez H, Druce PS, Ashton HA. Abdominal aortic aneurysm development inmen following a "normal" aortic ultrasound scan. Eur J Vasc Endovasc Surg 2008;36:553-8.
10. Kim LG, Thompson SG, Briggs AH, Buxton MJ, Campbell HE. How cost-effective is screening for abdominal aortic aneurysms? J Med Screen 2007;14:46-52.
11. Henriksson M, Lundgren F. Decision-analytical model with lifetime estimation of costs and health outcomes for one-time screening for abdominal aortic aneurysm in 65-year-old men. Br J Surg 2005;92:976-83.
12. Campbell HE, Briggs AH, Buxton MJ, Kim LG, Thompson SG. The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. J Health Serv Res Policy 2007;12:11-17.
13. Kim LG, Thompson SG. Uncertainty and validation of health economic decision models. Health Econ 2009 Feb 10 [Epub ahead of print].
14. Lin CC, Johnson NJ. Decomposition of life expectancy and expected life-years lost by disease. Stat Med 2006;25:1922-36.
15. Loeys T, Goetghebeur E. A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance. Biometrics 2003;59:100-5.
16. UK Department of Health. Impact assessment of a national screening programme for abdominal aortic aneurysms, Jul 2008. www.ialibrary.berr.gov.uk/ ImpactAssessment/.
17. Multicentre Aneurysm Screening Study Group. Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. BMJ 2002;325:1135-8.
18. Lin DY, Feuer EJ, Etzioni R, Wax Y. Estimating medical costs from incomplete follow-up data. Biometrics 1997;53:419-34.
19. Willan AR, Lin DY, Manca A. Regression methods for cost-effectiveness analysis with censored data. Stat Med 2005;24:131-45.
20. Willan AR, O'Brien BJ. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. Health Econ 1996;5:297-305.
21. Office for National Statistics. Review of the national statistician on deaths in England and Wales, 2007. www.statistics.gov.uk.
22. Brady AR, Thompson SG, Fowkes FGR, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 2004;110:16-21.
23. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004;329:224-7.
24. Wanhainen A, Lundkvist J, Bergqvist D, Björck M. Cost-effectiveness of different screening strategies for abdominal aortic aneurysm. J Vasc Surg 2005;41:741-51.
25. EVAR Trial Participants. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 2004;364:843-8.
26. EVAR Trial Participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 2005;365:2179-86.
27. Dutch Randomized Endovascular Aneurysm Management (DREAM) Trial Group. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med 2005;352:2398-405.
28. Lederle FA, Kane RL, MacDonald R, Wilt TJ. Systematic review: repair of unruptured abdominal aortic aneurysm. Ann Intern Med 2007;146:735-41.
29. Epstein DM, Sculpher MJ, Manca A, Michaels J, Thompson SG, Brown LC, et al. Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm. Br J Surg 2008;95:183-90.
30. EVAR Trial Participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 2005;365:2187-92.
31. National Institute for Health and Clinical Excellence. Abdominal aortic aneurysm - endovascular stent-grafts: technology appraisal, Feb 2009. www.nice.org.uk/Guidance/TA167.
32. Mani K, Björck M, Lundkvist J, Wanhainen A. Similar cost for elective open and endovascular AAA repair in a population-based setting. J Endovasc Ther 2008;15:1-11.
33. Brady AR, Fowkes FGR, Thompson SG, Powell JT. Aortic aneurysm diameter and the risk of cardiovascular mortality. Arteriosclerosis, thrombosis and vascular biology 2001;21:1203-7.
34. Guessous I, Periard D, Lorenzetti D, Cornuz J, Ghali WA. The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review andmeta-analysis. PLoS ONE 2008;3:e1895.
35. Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 2006;368:659-65.
36. Marteau TM, Kim LG, Upton J, Thompson SG, Scott RAP. Poorer self-assessed health in a prospective study of men with screen detected abdominal aortic aneurysm: a predictor or consequence of screening outcome? J Epidemiol Community Health 2004;58:1042-6.
37. Kind P, Hardman G, Macran S. UK population norms for EQ-5D. Discussion paper 172. University of York, Centre for Health Economics, 1999.